← Leaderboards
Harland S Winter
Massachusetts General Hospital
$1,653,812
Attributed
$1,653,812
Total exposure
4
Grants
0
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding mix
By agency
NIH$1,653,812 · 4
By mechanism
M01$1,620,812 · 3
R13$33,000 · 1
Top collaborators
No co-investigators on record.
Most similar at Massachusetts General Hospital
Same institution · by research overlap
- Sanjay K Nigam$28,101,639
- Allan M Goldstein$7,045,731
- Bruce E Sands$6,502,130
- Louise G Cohen$734,031
- Jean A Frazier$5,312,164
Others in their field
Top investigators on “Pediatric Pharmacology”
- Garret A Fitzgerald · University Of Pennsylvania$125,310,120
- Stephen A Spector · University Of California, San Diego$84,289,331
- Gregory H Reaman · National Childhood Cancer Foundation$80,145,837
- Constance Ann Benson · University Of California, San Diego$65,790,143
- David Eric Shapiro · Harvard University D/B/A Harvard School Of Public Health$63,773,218
- Kathryn Hirst · Caritas St. Elizabeth'S Medical Center$57,671,528
Research focus
Pediatric PharmacologyClinical ResearchDrug Screening /EvaluationGastrointestinal Disorder ChemotherapyHuman SubjectHuman Therapy EvaluationDrug Administration Rate /DurationClinical Trial Phase IGastrointestinal AgentsChild (0-11)Oral AdministrationPharmacokineticsBenzofuransBiopsyMiddle Childhood (6-11)ConstipationPreschool Child (1-5)Gastric Juice InhibitorReflux EsophagitisUlcerative ColitisAdolescence (12-20)NutritionMeeting /Conference /SymposiumCongenital Gastrointestinal Disorder
Grant awards (15)
Oral R108512 for Constipation in Children$200,768
M01 · FY2002 · RR
Lansoprazole Effects in Pediatric Esophagitis$200,768
M01 · FY2002 · RR
Lansoprazole Effects in Pediatric Esophagitis$200,768
M01 · FY2002 · RR
Oral R108512 for Constipation in Children$200,768
M01 · FY2002 · RR
Oral R108512 for Constipation in Children$200,768
M01 · FY2001 · RR
Lansoprazole Effects in Pediatric Esophagitis$200,768
M01 · FY2001 · RR
Lansoprazole Effects in Pediatric Esophagitis$0
M01 · FY2001 · RR
Oral R108512 for Constipation in Children$0
M01 · FY2001 · RR
RIDOGREL TABLETS IN CLINICALLY STABLE, NON ACTIVE PEDIATRIC PATIENTS$415,629
M01 · FY2000 · RR
NASPGN-WORLD CONGRESS OF PEDIATRIC GASTROENTEROLOGY$33,000
R13 · FY2000 · DK
RIDOGREL TABLETS IN CLINICALLY STABLE, NON ACTIVE PEDIATRIC PATIENTS$575
M01 · FY2000 · RR
Lansoprazole Effects in Pediatric Esophagitis$0
M01 · FY2000 · RR
Oral R108512 for Constipation in Children$0
M01 · FY2000 · RR
Oral R108512 for Constipation in Children$0
M01 · FY2000 · RR
Lansoprazole Effects in Pediatric Esophagitis$0
M01 · FY2000 · RR